Aemetis, Inc (NASDAQ:AMTX) – Investment analysts at B. Riley decreased their FY2017 earnings estimates for shares of Aemetis in a research note issued to investors on Monday. B. Riley analyst C. Driscoll now anticipates that the specialty chemicals company will post earnings per share of ($1.37) for the year, down from their previous forecast of ($1.20). B. Riley currently has a “Hold” rating and a $2.00 target price on the stock. B. Riley also issued estimates for Aemetis’ Q4 2017 earnings at ($0.25) EPS, Q1 2018 earnings at ($0.26) EPS, Q2 2018 earnings at ($0.25) EPS, Q3 2018 earnings at ($0.25) EPS, Q4 2018 earnings at ($0.24) EPS and FY2018 earnings at ($1.00) EPS.
Several other brokerages have also commented on AMTX. Zacks Investment Research upgraded shares of Aemetis from a “sell” rating to a “hold” rating in a research note on Thursday, July 20th. FBR & Co reiterated a “neutral” rating and issued a $2.00 price target on shares of Aemetis in a research note on Saturday, August 19th.
ILLEGAL ACTIVITY WARNING: “Aemetis, Inc (AMTX) to Post FY2017 Earnings of ($1.37) Per Share, B. Riley Forecasts” was first published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this story on another site, it was copied illegally and republished in violation of US & international trademark & copyright law. The correct version of this story can be read at https://ledgergazette.com/2017/11/15/aemetis-inc-amtx-to-post-fy2017-earnings-of-1-37-per-share-b-riley-forecasts.html.
Aemetis (AMTX) opened at $0.73 on Wednesday. Aemetis has a one year low of $0.53 and a one year high of $2.50. The company has a debt-to-equity ratio of -1.87, a current ratio of 0.37 and a quick ratio of 0.20.
An institutional investor recently bought a new position in Aemetis stock. Ninepoint Partners LP purchased a new position in shares of Aemetis, Inc (NASDAQ:AMTX) in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 1,151,373 shares of the specialty chemicals company’s stock, valued at approximately $1,002,000. Ninepoint Partners LP owned 5.81% of Aemetis at the end of the most recent reporting period. Institutional investors own 18.71% of the company’s stock.
Aemetis, Inc is an international renewable fuels and biochemicals company. The Company is focused on the production of fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products by conversion of first-generation ethanol and biodiesel plants into biorefineries.
Receive News & Ratings for Aemetis Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis Inc and related companies with MarketBeat.com's FREE daily email newsletter.